Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.20.2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
REVENUES $ 1,405 $ 79 $ 2,553 $ 276
OPERATING EXPENSES        
Research and development 4,413 4,609 14,720 13,628
Sales, marketing and administration 3,055 2,952 9,170 8,931
TOTAL OPERATING EXPENSES 7,468 7,561 23,890 22,559
NET OPERATING LOSS (6,063) (7,482) (21,337) (22,283)
OTHER INCOME (EXPENSE)        
Interest and investment income 1 42 65 220
Other expense (1) (7) (10) (18)
TOTAL OTHER INCOME, NET 0 35 55 202
LOSS BEFORE INCOME TAXES (6,063) (7,447) (21,282) (22,081)
Provision for income taxes 0 0 1 1
NET LOSS (6,063) (7,447) (21,283) (22,082)
Foreign currency translation adjustment, net of tax 27 (16) 44 (10)
COMPREHENSIVE LOSS $ (6,036) $ (7,463) $ (21,239) $ (22,092)
NET LOSS PER SHARE - BASIC AND DILUTED (in dollars per share) $ (0.11) $ (0.26) $ (0.43) $ (0.78)
Weighted average shares outstanding-basic and diluted (in shares) 53,243,854 29,169,495 50,004,688 28,295,248